American College of Cardiology Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with T2D and Atherosclerotic Cardiovascular Disease In 2018, the American College of Cardiology (ACC) published an expert consensus decision pathway on the use of novel therapies, namely GLP-1 RAs and SGLT-2 inhibitors, to reduce cardiovascular risk in patients with T2D
Remember, combining therapies can affect multiple hormone pathways
Natural Medicine of Stillwater does not guarantee specific results
S.NielsenR.HnselmannA.et al (2017)
Resistance Training: Progressive resistance training provides the stimulus for muscle maintenance and growth
How GLP-1s impact fertility Research shows that having high blood sugar and excess fat in the bodyeven if you dont have type 2 diabetescan affect whether you ovulate every month, Christina Boots, MD, a board-certified ob-gyn at Northwestern Medicine who specializes in reproductive endocrinology, tells SELF